DE2819131C2 - - Google Patents
Info
- Publication number
- DE2819131C2 DE2819131C2 DE2819131A DE2819131A DE2819131C2 DE 2819131 C2 DE2819131 C2 DE 2819131C2 DE 2819131 A DE2819131 A DE 2819131A DE 2819131 A DE2819131 A DE 2819131A DE 2819131 C2 DE2819131 C2 DE 2819131C2
- Authority
- DE
- Germany
- Prior art keywords
- thymus
- fetal
- extracts
- extract
- organ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000001541 thymus gland Anatomy 0.000 claims description 23
- 230000001605 fetal effect Effects 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 13
- 210000000056 organ Anatomy 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000007900 aqueous suspension Substances 0.000 claims description 3
- 244000309466 calf Species 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 2
- 238000004182 chemical digestion Methods 0.000 claims description 2
- 210000003754 fetus Anatomy 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 230000000366 juvenile effect Effects 0.000 claims 1
- 238000012792 lyophilization process Methods 0.000 claims 1
- 238000010790 dilution Methods 0.000 description 10
- 239000012895 dilution Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229940034252 thymus extracts Drugs 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000002032 cellular defenses Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782819131 DE2819131A1 (de) | 1978-04-29 | 1978-04-29 | Arzneimittel aus thymus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782819131 DE2819131A1 (de) | 1978-04-29 | 1978-04-29 | Arzneimittel aus thymus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2819131A1 DE2819131A1 (de) | 1979-11-08 |
| DE2819131C2 true DE2819131C2 (OSRAM) | 1989-04-06 |
Family
ID=6038459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782819131 Granted DE2819131A1 (de) | 1978-04-29 | 1978-04-29 | Arzneimittel aus thymus |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2819131A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE22801T1 (de) * | 1981-11-26 | 1986-11-15 | Heinrich Dr Med Ollendiek | Verfahren zur extraktion der thymusdruese. |
| FR2599972B1 (fr) * | 1986-06-12 | 1990-06-29 | Laumond Gerard | Extraits tissulaires embryonnaires d'organes animaux, injectables a l'homme |
-
1978
- 1978-04-29 DE DE19782819131 patent/DE2819131A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2819131A1 (de) | 1979-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Prutkin | Antitumor activity of vitamin A acid and fluorouracil used in combination on the skin tumor, keratoacanthoma | |
| DE1195905B (de) | Verfahren zum Abtrennen der Zellwaende von Mycobacterium phlei | |
| DD272034A5 (de) | Verfahren zur herstellung einer praeparation zur regulierung des gewebewachstums | |
| EP0029893A2 (de) | Verfahren zur Anreicherung tumorhemmender Wirkfaktoren | |
| CH404858A (de) | Verfahren zur Herstellung von wachstumfördernde Stoffe enthaltenden Präparaten | |
| DE2234832C2 (de) | Proteinfreies Hormonkonzentrat von Säugetier-Nebenschilddrüsen, dessen Herstellung und dieses Hormonkonzentrat enthaltende pharmazeutische Präparate | |
| DE2819131A1 (de) | Arzneimittel aus thymus | |
| DE2656333A1 (de) | Zusaetzliches verfahren zur herstellung von liposomen mit zelltropismus und verbesserter permeabilitaet zur applikation von arzneimitteln | |
| DD209969A5 (de) | Haarwuchsmittel | |
| DE832321C (de) | Verfahren zur Gewinnung eines Arzneimittels zur Behandlung von auf hemmungslosem Wachstum von Zellen o. dgl. beruhenden Erkrankungen, wie Leukaemie usw. | |
| CH713107A2 (de) | Synthetische Kamel-Organ-Extrakte, Verfahren zu ihrer Herstellung und ihre Verwendung. | |
| EP0040604B1 (de) | Kosmetische zubereitung | |
| DE973249C (de) | Verfahren zur Gewinnung von injizierbaren Loesungen aus Frischplacenta | |
| DE1492075C3 (de) | Kosmetisches Mittel zur Unterstützung der Behandlung bei Haarausfall und/oder Seborrhoe sowie Verfahren zur Herstellung derselben | |
| CH671516A5 (OSRAM) | ||
| DE1802386C2 (de) | Verfahren zur Gewinnung von cytobiotischen Globulinen | |
| DE2511285C3 (de) | Kosmetisches Mittel und Herstellungsverfahren dafür | |
| DE962781C (de) | Verfahren zur Erzeugung einer Vitamin-D-reichen Hefezubereitung | |
| DE2034118A1 (en) | Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins | |
| DE3485773T2 (de) | Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten. | |
| DE69331704T2 (de) | Biologisch aktive substanz mit immunmodulierenden eigenschaften, verfahren zu ihrer gewinnung und aus ihr hergestellte, pharmazeutische zubereitung | |
| DE837833C (de) | Verfahren zur Herstellung eines Thrombokinasepraeparates | |
| AT200257B (OSRAM) | ||
| DE876441C (de) | Verfahren zur Herstellung eines Wirkkoerpers aus Weissdorn | |
| DE556526C (de) | Verfahren zur Darstellung von hochwirksamen Extrakten aus tierischen und pflanzlichen Bestandteilen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition |